Sen. Maggie Hassan (D-NH) (Photo by Michael Brochstein/Sipa USA)(Sipa via AP Images)
May 1, 2024 03:04 PM EDTUpdated 03:27 PM
Pharma
FDA+

Sen­a­tor al­leges GSK is shirk­ing its com­mit­ment to low­er in­haler costs

Lia DeGroot

Sen. Mag­gie Has­san (D-NH) is pres­sur­ing GSK to put a com­mon­ly used pe­di­atric in­haler back on the mar­ket af­ter the com­pa­ny stopped pro­duc­ing it in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Among phar­ma CEOs, the IRA now and the IRA lat­er get very dif­fer­ent re­ac­tions

Up­dat­ed: With cost-cut­ting un­der­way, Bris­tol My­ers rais­es guid­ance, touts Phase 3 win and scraps an­oth­er

Bris­tol My­ers restarts ra­dio­phar­ma­ceu­ti­cal Phase 3 tri­al, but de­lays read­out by one year

An­drew Left, short sell­er who cam­paigned against Valeant, is ac­cused of fraud by SEC

Eu­ro­pean drug reg­u­la­tor re­jects Alzheimer's drug Leqem­bi, cit­ing safe­ty con­cerns

sponsored

Crit­i­cal Junc­tures in Gene Ther­a­py Clin­i­cal Ma­te­r­i­al Man­u­fac­tur­ing: Where Do I Start? And Will It Work?

A service from the Financial Times